Growing Demand for DuPont Renewable Products Drives Global Commercialization

PRNewswire

DuPont Updates Investors on its Applied BioSciences Business
VONORE and LOUDON, Tenn., May 11 /PRNewswire-FirstCall/ -- DuPont (NYSE: DD) is executing a rapid commercialization strategy in its Applied BioSciences business for a diverse portfolio of high-performance, renewable products that address the needs of large markets, DuPont leaders told security analysts and investors. As a result, the company has set goals for the Applied BioSciences business of $1 billion in revenue and $250 million in pretax earnings by 2015.

"DuPont is uniquely positioned to lead in industrial biotechnology. We are connecting our core technology capabilities to markets that can be transformed by our science and this strategy is beginning to pay off," said Thomas M. Connelly, DuPont executive vice president and chief innovation officer. "The Applied BioSciences portfolio is developing solutions to reduce dependence on fossil fuels, and continues to be one of the most significant growth opportunities in the company's history."

Read more